Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.32 |
| ▸ | BCHE | P06276 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9131101 | 1.00 | LMNA (0.33) | LMNAL3MBTL1BCHEKMT2A | |
| SCHEMBL9127158 | 0.89 | ALDH1A1 (0.30) | — | |
| SCHEMBL9019538 | 0.89 | ALDH1A1 (0.30) | — | |
| SCHEMBL9019595 | 0.84 | LMNA (0.36) | LMNABCHEKMT2A | |
| SCHEMBL9128912 | 0.84 | LMNA (0.36) | LMNABCHEKMT2A | |
| SCHEMBL9130221 | 0.80 | L3MBTL1 (0.44) | LMNAL3MBTL1 | |
| SCHEMBL9019616 | 0.78 | ALDH1A1 (0.37) | LMNAL3MBTL1KMT2A | |
| SCHEMBL9127050 | 0.78 | ALDH1A1 (0.37) | LMNAL3MBTL1KMT2A | |
| SCHEMBL9127537 | 0.78 | LMNA (0.39) | LMNAL3MBTL1 | |
| SCHEMBL9127645 | 0.77 | MAPT (0.38) | LMNAL3MBTL1BCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0515420-B1 | NITRIC ACID ESTERS OF CYCLOHEXANOL DERIVATIVES | BOEHRINGER MANNHEIM GMBH (DE) | 1996-06-12 | — | — | EP | disclosed |
| EP-0515420-A1 | NITRIC ACID ESTERS OF CYCLOHEXANOL DERIVATIVES. | BOEHRINGER MANNHEIM GMBH (DE) | 1992-12-02 | — | — | EP | disclosed |
| WO-1991012230-A1 | NITRIC ACID ESTERS OF CYCLOHEXANOL DERIVATIVES | BOEHRINGER MANNHEIM GMBH (DE) | 1991-08-22 | — | — | WO | disclosed |